Home › Acute Lymphoblastic Leukemia › California › Los Angeles
Acute Lymphoblastic Leukemia clinical trials in Los Angeles, CA
14 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
Recruiting
- Children's Hospital of Los Angeles, Los Angeles
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
RecruitingPhase 2
- Children's Hospital Los Angeles, Los Angeles
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Children's Hospital Los Angeles, Los Angeles
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RecruitingPhase 2
- Children's Hospital Los Angeles, Los Angeles
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
RecruitingObservational study
- University of California Los Angeles, Los Angeles
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
RecruitingPhase 1
- Cedars-Sinai Medical Center, Los Angeles
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- UCLA, Los Angeles
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
RecruitingPhase 1/2
- Children's Hospital Los Angeles, Los Angeles
Pharmacogenomics of Asparaginase Induced Hepatotoxicity
RecruitingObservational study
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
RecruitingPhase 3
- Ascentage Investigative Site #1134, Los Angeles
- Ascentage Investigative Site #1059, Los Angeles
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
RecruitingPhase 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Bright Ideas - CIN Feasibility Study
Recruiting
- Children's Hospital Los Angeles, Los Angeles
Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy
Recruiting
- Jackie and Gene Autry Orthopedic Center, CHLA, Los Angeles
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecruitingPhase 1
- Children's Hospital Los Angeles, Los Angeles
Acute Lymphoblastic Leukemia trials in other cities
- Houston, TX28 studies
- New York City, NY24 studies
- Seattle, WA21 studies
- Baldwin Park, CA21 studies
- Chicago, IL19 studies
- Atlanta, GA18 studies
- Memphis, TN16 studies
- Washington, DC16 studies
- Philadelphia, PA16 studies
- Boston, MA15 studies
- Mountain View, CA13 studies
- Durham, NC13 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)73 studies
- Breast Cancer71 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer49 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer36 studies
- Endometrial Cancer35 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.